Literature DB >> 16043456

Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes.

J K Swanton1, K Fernando, C M Dalton, K A Miszkiel, A J Thompson, G T Plant, D H Miller.   

Abstract

BACKGROUND: The McDonald criteria include MRI evidence for dissemination in space and dissemination in time for the diagnosis of multiple sclerosis in young adult patients who present with clinically isolated syndromes (CIS) typical of the disease. Although a major advance, the criteria have limited sensitivity for making an early diagnosis.
OBJECTIVE: To compare the performance of McDonald criteria and modified McDonald criteria for dissemination in space and time for assessing the development of clinically definite multiple sclerosis.
METHODS: McDonald criteria were modified using the combination of a less stringent definition for dissemination in space and allowing a new T2 lesion per se after three months as evidence for dissemination in time. Modified and McDonald criteria were applied in 90 CIS patients at baseline and at three month follow up scans.
RESULTS: Both criteria were highly specific (>90%) but the modified criteria were more sensitive (77% v 46%) and more accurate (86% v 73%).
CONCLUSIONS: These modified criteria should be evaluated in other CIS cohorts.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16043456      PMCID: PMC2117493          DOI: 10.1136/jnnp.2005.073247

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  10 in total

1.  Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis.

Authors:  M Tintoré; A Rovira; M J Martínez; J Rio; P Díaz-Villoslada; L Brieva; C Borrás; E Grivé; J Capellades; X Montalban
Journal:  AJNR Am J Neuroradiol       Date:  2000-04       Impact factor: 3.825

2.  New diagnostic criteria for multiple sclerosis: application in first demyelinating episode.

Authors:  M Tintoré; A Rovira; J Río; C Nos; E Grivé; J Sastre-Garriga; I Pericot; E Sánchez; M Comabella; X Montalban
Journal:  Neurology       Date:  2003-01-14       Impact factor: 9.910

Review 3.  Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis.

Authors:  F Barkhof; M Filippi; D H Miller; P Scheltens; A Campi; C H Polman; G Comi; H J Adèr; N Losseff; J Valk
Journal:  Brain       Date:  1997-11       Impact factor: 13.501

4.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

5.  Is optic neuritis more benign than other first attacks in multiple sclerosis?

Authors:  Mar Tintoré; Alex Rovira; Jordi Rio; Carlos Nos; Elisensa Grivé; Neus Téllez; Raul Pelayo; Manuel Comabella; Xavier Montalban
Journal:  Ann Neurol       Date:  2005-02       Impact factor: 10.422

Review 6.  Multiple sclerosis diagnostic criteria: three years later.

Authors:  Chris H Polman; Jerry S Wolinsky; Stephen C Reingold
Journal:  Mult Scler       Date:  2005-02       Impact factor: 6.312

7.  Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis.

Authors:  Catherine M Dalton; Peter A Brex; Katherine A Miszkiel; Simon J Hickman; David G MacManus; Gordon T Plant; Alan J Thompson; David H Miller
Journal:  Ann Neurol       Date:  2002-07       Impact factor: 10.422

8.  New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes.

Authors:  Catherine M Dalton; Peter A Brex; Katherine A Miszkiel; Kryshani Fernando; David G MacManus; Gordon T Plant; Alan J Thompson; David H Miller
Journal:  Ann Neurol       Date:  2003-05       Impact factor: 10.422

Review 9.  Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis.

Authors:  D H Miller; M Filippi; F Fazekas; J L Frederiksen; P M Matthews; X Montalban; C H Polman
Journal:  Ann Neurol       Date:  2004-08       Impact factor: 10.422

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

  10 in total
  41 in total

1.  Optimizing outcomes in multiple sclerosis: consensus guidelines for the diagnosis and treatment of multiple sclerosis in Latin America.

Authors:  Adriana Carrá; Miguel Ángel Macías-Islas; Alberto Alan Gabbai; Jorge Correale; Carlos Bolaña; Eduardo Duriez Sotelo; Juan García Bonitto; Fernando Vergara-Edwards; Darwin Vizcarra-Escobar
Journal:  Ther Adv Neurol Disord       Date:  2011-11       Impact factor: 6.570

2.  From injection therapies to natalizumab: views on the treatment of multiple sclerosis.

Authors:  Roberto Bomprezzi; Darin T Okuda; Yazan J Alderazi; Olaf Stüve; Elliot M Frohman
Journal:  Ther Adv Neurol Disord       Date:  2012-03       Impact factor: 6.570

3.  [Revision of McDonald's new diagnostic criteria for multiple sclerosis].

Authors:  H Wiendl; B C Kieseier; R Gold; R Hohlfeld; M Bendszus; H-P Hartung
Journal:  Nervenarzt       Date:  2006-10       Impact factor: 1.214

4.  [Diagnosis of multiple sclerosis 2010 revision of the McDonald criteria].

Authors:  L Klotz; R Gold; B Hemmer; T Korn; F Zipp; R Hohlfeld; B C Kieseier; H Wiendl
Journal:  Nervenarzt       Date:  2011-10       Impact factor: 1.214

5.  Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score.

Authors:  Paolo Invernizzi; Laura Bertolasi; Maria Rachele Bianchi; Marco Turatti; Alberto Gajofatto; Maria Donata Benedetti
Journal:  J Neurol       Date:  2011-04-09       Impact factor: 4.849

Review 6.  The radiologically isolated syndrome: look (again) before you treat.

Authors:  Rebecca Spain; Dennis Bourdette
Journal:  Curr Neurol Neurosci Rep       Date:  2011-10       Impact factor: 5.081

7.  Criteria improving multiple sclerosis diagnosis at the first MRI.

Authors:  Nathalie Caucheteux; Adil Maarouf; Margaux Genevray; Emmanuelle Leray; Romain Deschamps; Marie P Chaunu; Laure Daelman; Jean C Ferré; Olivier Gout; Jean Pelletier; Laurent Pierot; Gilles Edan; Ayman Tourbah
Journal:  J Neurol       Date:  2015-02-17       Impact factor: 4.849

Review 8.  Grey matter lesions in MS: from histology to clinical implications.

Authors:  Massimiliano Calabrese; Alice Favaretto; Valeria Martini; Paolo Gallo
Journal:  Prion       Date:  2012-10-23       Impact factor: 3.931

Review 9.  MRI in multiple sclerosis: current status and future prospects.

Authors:  Rohit Bakshi; Alan J Thompson; Maria A Rocca; Daniel Pelletier; Vincent Dousset; Frederik Barkhof; Matilde Inglese; Charles R G Guttmann; Mark A Horsfield; Massimo Filippi
Journal:  Lancet Neurol       Date:  2008-07       Impact factor: 44.182

10.  The diagnosis of multiple sclerosis and the clinical subtypes.

Authors:  Barrie J Hurwitz
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.